2-[2-fluoro-5-(methyloxy)phenyl]-1H-imidazole-4-carbaldehyde | 1338346-15-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-[2-fluoro-5-(methyloxy)phenyl]-1H-imidazole-4-carbaldehyde
• 英文别名: 2-(2-fluoro-5-methoxyphenyl)-1H-imidazole-5-carbaldehyde
• CAS: 1338346-15-8
• 化学式: C₁₁H₉FN₂O₂
• 分子量: 220.203
• InChiKey: SCJQENBBDPJGRW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  55
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-[2-fluoro-5-(methyloxy)phenyl]-1H-imidazole-4-carbaldehyde 、 3-amino-N-methyl-4-{[2-(methyloxy)ethyl]amino}benzamide 在 sodium hydrogensulfite 作用下， 以 乙醇 、 水 为溶剂， 反应 0.08h， 以71%的产率得到2-{2-[2-fluoro-5-(methyloxy)phenyl]-1H-imidazol-4-yl}-N-methyl-1-[2-(methyloxy)ethyl]-1H-benzimidazole-5-carboxamide
  参考文献：
  名称：

  [EN] IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
  [FR] IMIDAZOLYL-IMIDAZOLES EN TANT QU'INHIBITEURS DE KINASE

  摘要：

  揭示了具有以下公式的化合物：其中R1A、R1B、R2和R3如本文所定义，并且制备和使用这些化合物的方法。

  公开号：

  WO2011123609A1
• 作为产物：
  描述：

  2-氟-5-甲氧基苯甲腈 在 manganese(IV) oxide 、 ammonium hydroxide 、 氯化铵 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 氯仿 、 水 为溶剂， 反应 5.5h， 生成 2-[2-fluoro-5-(methyloxy)phenyl]-1H-imidazole-4-carbaldehyde
  参考文献：
  名称：

  [EN] IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
  [FR] IMIDAZOLYL-IMIDAZOLES EN TANT QU'INHIBITEURS DE KINASE

  摘要：

  揭示了具有以下公式的化合物：其中R1A、R1B、R2和R3如本文所定义，并且制备和使用这些化合物的方法。

  公开号：

  WO2011123609A1

文献信息

• IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
  申请人：Bodmer Vera Q.

  公开号：US20130018039A1

  公开（公告）日：2013-01-17

  Disclosed are compounds having the formula: wherein R 1A , R 1B , R 2 and R 3 are defined herein, and methods of making and using the same.

  本发明涉及具有以下式的化合物：其中R1A，R1B，R2和R3如本文所定义，并且涉及其制备和使用的方法。
• Bi-functional complexes and methods for making and using such complexes
  申请人：Gouliaev Alex Haahr

  公开号：US11225655B2

  公开（公告）日：2022-01-18

  The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.

  本发明涉及一种合成双功能复合物的方法，该复合物包括分子部分和识别分子部分的识别寡核苷酸部分。根据本发明的合成方法的一部分优选在一种或多种有机溶剂中进行，此时包含可选保护标签或寡核苷酸标识符的新生双功能复合物与固体支持物相连接，合成方法的另一部分优选在适合于将寡核苷酸标签酶加到溶液中的新生双功能复合物的条件下进行。
• BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
  申请人：Nuevolution A/S

  公开号：EP2558577A1

  公开（公告）日：2013-02-20
• BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
  申请人：Gouliaev Alex Haahr

  公开号：US20130281324A1

  公开（公告）日：2013-10-24

  The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
• [EN] BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES<br/>[FR] COMPLEXES BIFONCTIONNELS ET PROCÉDÉS DE FABRICATION ET D'UTILISATION DE TELS COMPLEXES
  申请人：NUEVOLUTION AS

  公开号：WO2011127933A1

  公开（公告）日：2011-10-20

  The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.